🔴 HCW Biologics is trading 5.78% down today after going-concern warning

HCW Biologics is trading 5.78% down now at $2.52 after investors continued reacting to the August 14, 2026 earnings release.

• Second-quarter net loss widened to $5.2 million from $1.9 million, while licensing revenue was $135,568.
• Management disclosed substantial doubt about going concern for at least 12 months without additional funding; full HCW9302 Phase 1 data remains on track for the fourth quarter.
• Shares closed August 14, 2026 at $2.68, down 8.38%, indicating sustained selling.